Many are calling for health care price controls. In @nytopinion, Lorens Helmchen and I argue that price controls rest on a heroic assumption: regulators can know the right price and keep it from being shaped by the industries regulated. The answer isn’t price by decree.
The editors of the @NEJM recently invoked Stalin's infamous agronomist Trofim Lysenko to warn of where the administration's proposed "political review" of NIH grants will lead. 🧵
Maybe you've seen the PhRMA ad with the tall hospital executive named "Mark" telling staff to "markup" drug prices. But what's the program behind the gag?
My new @Forbes piece on 340B: how a tiny 1992 safety-net program became an $81B opaque revenue mechanism most Americans have
What can a health economist tell you about peptide dosing or longevity stacks? Nothing. But I have thoughts on what the peptide moment says about risk, regulation, and who gets to decide. New in @medpagetoday: